These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition. Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102 [TBL] [Abstract][Full Text] [Related]
7. Treatment of drug-resistant hypertension with minoxidil or angiotensin-converting enzyme inhibitor: blood pressure, renin, aldosterone, and electrolyte responses. Baer L; Radichevich I; Williams GS J Cardiovasc Pharmacol; 1980; 2 Suppl 2():S206-16. PubMed ID: 6156357 [TBL] [Abstract][Full Text] [Related]
8. Effect of tolvaptan on renal water and sodium excretion and blood pressure during nitric oxide inhibition: a dose-response study in healthy subjects. Al Therwani S; Rosenbæk JB; Mose FH; Bech JN; Pedersen EB BMC Nephrol; 2017 Mar; 18(1):86. PubMed ID: 28288570 [TBL] [Abstract][Full Text] [Related]
9. Preliminary observations of the acute effects of selective serum thromboxane inhibition and angiotensin converting enzyme inhibition on blood pressure and renal hemodynamics in hypertensive humans. Weir MR; Klassen DK; Hoover N; Douglas FL J Clin Pharmacol; 1989 Dec; 29(12):1108-16. PubMed ID: 2693500 [TBL] [Abstract][Full Text] [Related]
10. Dietary salt produces abnormal renal vasoconstrictor responses to upright posture in borderline hypertensive subjects. Lawton WJ; Sinkey CA; Fitz AE; Mark AL Hypertension; 1988 Jun; 11(6 Pt 1):529-36. PubMed ID: 3384469 [TBL] [Abstract][Full Text] [Related]
11. Sodium and potassium excretion in normotensive and hypertensive population in Kashmir. Jan RA; Shah S; Saleem SM; Waheed A; Mufti S; Lone MA; Ashraf M J Assoc Physicians India; 2006 Jan; 54():22-6. PubMed ID: 16649734 [TBL] [Abstract][Full Text] [Related]
12. Crossover comparison of the effects of enalapril and captopril on potassium homeostasis in patients with mild hypertension. Ohya Y; Ueno M; Takata Y; Tominaga M; Ohmori S; Kobayashi K; Abe I; Fujishima M Int J Clin Pharmacol Ther; 1994 Dec; 32(12):655-9. PubMed ID: 7881704 [TBL] [Abstract][Full Text] [Related]
13. Effect of amiloride and spironolactone on renal tubular function and central blood pressure in patients with arterial hypertension during baseline conditions and after furosemide: a double-blinded, randomized, placebo-controlled crossover trial. Matthesen SK; Larsen T; Vase H; Lauridsen TG; Jensen JM; Pedersen EB Clin Exp Hypertens; 2013; 35(5):313-24. PubMed ID: 22966789 [TBL] [Abstract][Full Text] [Related]
14. Effects of sodium and potassium supplementation on blood pressure and arterial stiffness: a fully controlled dietary intervention study. Gijsbers L; Dower JI; Mensink M; Siebelink E; Bakker SJ; Geleijnse JM J Hum Hypertens; 2015 Oct; 29(10):592-8. PubMed ID: 25673113 [TBL] [Abstract][Full Text] [Related]
15. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group. Laffel LM; McGill JB; Gans DJ Am J Med; 1995 Nov; 99(5):497-504. PubMed ID: 7485207 [TBL] [Abstract][Full Text] [Related]
16. Association of urinary sodium and potassium excretion with blood pressure. Mente A; O'Donnell MJ; Rangarajan S; McQueen MJ; Poirier P; Wielgosz A; Morrison H; Li W; Wang X; Di C; Mony P; Devanath A; Rosengren A; Oguz A; Zatonska K; Yusufali AH; Lopez-Jaramillo P; Avezum A; Ismail N; Lanas F; Puoane T; Diaz R; Kelishadi R; Iqbal R; Yusuf R; Chifamba J; Khatib R; Teo K; Yusuf S; N Engl J Med; 2014 Aug; 371(7):601-11. PubMed ID: 25119606 [TBL] [Abstract][Full Text] [Related]
17. The effects of captopril on blood pressure, urinary water and electrolyte excretion and drinking behaviour in Brattleboro rats. Gardiner SM; Bennett T Clin Sci (Lond); 1983 Dec; 65(6):589-97. PubMed ID: 6354558 [TBL] [Abstract][Full Text] [Related]
18. The interaction between atrial natriuretic peptides and angiotensin II in controlling sodium and water excretion in the rat. Chamienia AL; Johns EJ Br J Pharmacol; 1991 Aug; 103(4):1893-8. PubMed ID: 1833019 [TBL] [Abstract][Full Text] [Related]
19. A comparison of the effect of lisinopril and hydrochlorothiazide on electrolyte balance in essential hypertension. Frewin DB; Bartholomeusz RC; Gaffney RD; Clampett AD; Chatterton BE Eur J Clin Pharmacol; 1992; 42(5):487-90. PubMed ID: 1318845 [TBL] [Abstract][Full Text] [Related]
20. Effect of the novel orally active angiotensin converting enzyme inhibitor alacepril on cardiovascular system in experimental animals. Takeyama K; Minato H; Nakatsuji K; Suzuki H; Nose I; Oka M; Hosoki K; Hatano N; Kadokawa T Arzneimittelforschung; 1986; 36(1):69-73. PubMed ID: 3513779 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]